Li, Ang
Huang, Sen
Cao, Shu-qin
Lin, Jinyi
Zhao, Linping https://orcid.org/0000-0002-3912-0056
Yu, Feng
Huang, Miaodan https://orcid.org/0000-0001-6600-8804
Yang, Lele
Xin, Jiaqi
Wen, Jing
Yan, Lingli
Zhang, Ke
Jiang, Maoyuan
Le, Weidong
Li, Peng
Liu, Yong U
Qin, Dajiang
Lu, Jiahong https://orcid.org/0000-0002-1147-125X
Lu, Guang https://orcid.org/0000-0002-2268-1033
Shen, Hanming https://orcid.org/0000-0001-7369-5227
Yao, Xiaoli https://orcid.org/0000-0003-2613-7956
Fang, Evandro F https://orcid.org/0000-0003-0355-7202
Su, Huanxing https://orcid.org/0000-0003-3254-825X
Funding for this research was provided by:
Macau University of Science and Technology (0093/2024/AFJ)
MOST | National Natural Science Foundation of China (#81971327)
MOST | National Natural Science Foundation of China (#82271448)
MOST | National Natural Science Foundation of China (MYRGGRG2023-00152-ICMS-UMDF)
Cure Alzheimer's Fund (#282952; #284930)
research council of Norway (#262175,#334361)
HELSE SOR-OST (2020001,#2021021,#2023093)
Molecule AG/VITADAO (#282942)
NordForsk (#119986)
Høgskolen i Oslo og Akershus (269901,#261973,#262960)
civitan norges forskningsfond for Alzheimer skydom (#281931)
Ministerstvo Práce a Sociálních Věcí České Republiky (TO01000215)
horizon-TMA-MSCA-DN (#101073251)
Burroughs Wellcome Fund (#104617)
Science and Technology Development Fund, MAR (SKL-QRCM(UM)-2023-2025)
Science and Technology Development Fund, MAR (001/2023/ALC)
Article History
Received: 1 May 2025
Revised: 26 September 2025
Accepted: 1 October 2025
First Online: 15 October 2025
Disclosure and competing interests statement
: EFF is co-owner of Fang-S Consultation AS (Organization number 931 410 717) and NO-Age AS (Organization number 933 219 127). EFF also has an MTA with LMITO Therapeutics Inc (South Korea), a CRADA with ChromaDex (USA), a commercialization agreement with Molecule AG/VITADAO, and is a consultant to MindRank AI (China), NYO3 (Norway), and AgeLab (Vitality Nordic AS, Norway). SQC has a commercialization agreement with Molecule AG/VITADAO.